Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Kinase profiling for therapy selection in pretreated advanced cancer
NL-OMON22647Recruiting
- Sponsor
- Prof. dr. H.M.W. Verheul, M.D., Ph.D. Head Department of Medical Oncology VU University Medical Center De Boelelaan 1117 1081 HV Amsterdam The Netherlands Tel: +31 (0)20-4444321/300 Fax: + 31 (0)20-4444079 Email: [email protected]
- Start
- Sep 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of sunitinib, sorafenib and erlotinib in Nonhematologic neoplasms, sponsored by Prof. dr. H.M.W. Verheul, M.D., Ph.D. Head Department of Medical Oncology VU University Medical Center De Boelelaan 1117 1081 HV Amsterdam The Netherlands Tel: +31 (0)20-4444321/300 Fax: + 31 (0)20-4444079 Email: [email protected]. Primary endpoint: Clinical benefit rate. Started Sep 2010; status: recruiting.
02
Drugs
sunitinibsorafeniberlotinib
03
Conditions
Nonhematologic neoplasms
Beyond the preview
Go deeper on NL-OMON22647.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON22647.